Glaxo Smith Kline (BIOC.CA) - Board Of Directors' Decisions
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The board of directors' decisions held on 31/03/2021 .
The Decisions (505 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The board of directors' decisions held on 31/03/2021 .
The Decisions (505 KB)
Comments